4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Novartis AG (NOVN) operates in the Drug Manufacturers - General industry and is headquartered in Basel, Switzerland with about 75,267 employees. Its market capitalization is roughly $233 billion. In the fiscal year ended 2025-12-31, NOVN reported $56.7B in revenue and $14.0B in net income.
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $56.7B | $51.7B | $46.7B | $43.5B | — |
| Gross Profit | $43.0B | $38.9B | $34.2B | $31.9B | — |
| Operating Income (EBIT) | $17.6B | $14.5B | $9.8B | $7.9B | — |
| Net Income | $14.0B | $11.9B | $14.8B | $7.0B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $15.0B | $13.5B | $13.9B | $14.4B | $14.8B | — |
| Gross Profit | $11.2B | $10.1B | $10.2B | $10.8B | $11.5B | — |
| Operating Income (EBIT) | $4.8B | $4.2B | $3.6B | $4.5B | $4.9B | — |
| Net Income | $3.3B | $3.2B | $2.4B | $3.9B | $4.0B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | ($7.8B) | ($7.6B) | ($7.3B) | ($7.5B) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Dividends Paid | ($2.9B) | ($6.2B) | $0M | — | ($2.5B) | ($5.3B) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $110.9B | $102.2B | $99.9B | $117.5B | — |
| Total Liabilities | $64.4B | $58.1B | $53.2B | $58.0B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NOVN viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms